Seagen to Present at the J.P. Morgan Healthcare Conference

Click to copy

Press release content from Business Wire. The AP news staff was not involved in its creation.

Click to copy

Seagen to Present at the J.P. Morgan Healthcare Conference

PRESS RELEASE: Paid content from Business Wire

Press release content from Business Wire. The AP news staff was not involved in its creation.

December 20, 2022 GMT

BOTHELL, Wash.--(BUSINESS WIRE)--Dec 20, 2022--

Seagen Inc. (Nasdaq:SGEN) today announced that management will present at the 41 st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 3:00 p.m. Pacific Time. The presentation will be webcast live and available for replay from the investor section of Seagen’s website at investor.seagen.com.

About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.

View source version on businesswire.com:https://www.businesswire.com/news/home/20221220005200/en/

CONTACT: For Investors

Douglas Maffei, Ph.D.

(425) 527-4881

dmaffei@seagen.comFor Media

David Caouette

(310) 430-3476

dcaouette@seagen.com

KEYWORD: UNITED STATES NORTH AMERICA WASHINGTON

INDUSTRY KEYWORD: SCIENCE BIOTECHNOLOGY RESEARCH PETS ONCOLOGY HEALTH CONSUMER CLINICAL TRIALS

SOURCE: Seagen Inc.

PUB: 12/20/2022 08:00 AM/DISC: 12/20/2022 08:02 AM

http://www.businesswire.com/news/home/20221220005200/en